Inside these posts: Depomed

Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.


FDA accepts filing for drug licensed to Abbott unit

Reuters | Depomed Inc. said U.S. health regulators accepted the company’s
marketing application for its experimental pain drug, triggering a $10
million milestone payment from its licensee and sending its shares up 12

Get the full story »